Article thumbnail

Human menopausal gonadotropin-induced bioprosthetic valve thrombosis

By Rami Mahmood Abazid, Mohamed Shoman, Osama A Smettie and Osama A Elamin

Abstract

Bioprosthetic valve thrombosis (BPVT) is a rare but potentially life-threatening complication. Human menopausal gonadotropin (hMG) is commonly used for ovulation induction and has been associated with arterial and venous thrombosis. We reported a case of BPVT related to in vitro fertilization in a 39-year-old female, who underwent redo mitral valve replacement. To the best of our knowledge, this is the first case of hMG-induced BPVT in a young female patient

Topics: Bioprosthetic valve thrombosis, human menopausal gonadotropin, in vitro fertilization, Medicine, R
Publisher: Wolters Kluwer Medknow Publications
Year: 2018
DOI identifier: 10.4103/ajm.AJM_83_18
OAI identifier: oai:doaj.org/article:0675a94e5dd24ddda6dd1cc45f36ae8e
Journal:
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • https://doaj.org/article/0675a... (external link)
  • http://www.avicennajmed.com/ar... (external link)
  • https://doaj.org/toc/2231-0770 (external link)
  • Suggested articles


    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.